Finerenone and SGLT2 Inhibitors in Non-Diabetic CKD: Insights From FIND-CKD

Explore FIND-CKD data on finerenone in patients with CKD without diabetes, including outcomes by SGLT2 inhibitor use and implications for practice.

Chernery
Media formats available
  • Completing the pre-test is required to access this content.
    Pre-Survey
    Completing the pre-survey is required to access this content.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free